Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 29, 2016 02:02 ET | Source: AstraZeneca PLC

TAGRISSO APPROVED IN JAPAN FOR CANCER PATIENTS

TAGRISSO™ (OSIMERTINIB) approved in japan for PATIENTS WITH EGFR T790M mutation -positive metastatic non-small cell lung cancer Full approval is based on two Phase II trials, AURA extension and...
March 29, 2016 01:00 ET | Source: Sanofi Winthrop Industrie

Sanofi nomme le Dr Yong-Jun Liu au poste de Responsable de la Recherche

Sanofi nomme le Dr Yong-Jun Liu au poste de Responsable de la Recherche Paris, France - Le 29 mars 2016 - Sanofi annonce aujourd'hui la nomination du Dr Yong-Jun Liu au poste de Responsable...
March 29, 2016 01:00 ET | Source: Sanofi Winthrop Industrie

Sanofi Appoints Dr. Yong-Jun Liu as Head of Research

Sanofi Appoints Dr. Yong-Jun Liu as Head of Research Paris, France - March 29, 2016 - Sanofi announced today the appointment of Dr. Yong-Jun Liu as Head of Research, Global R&D, effective...
March 28, 2016 21:00 ET | Source: Intrinsic4D

Intrinsic4D Signs U.S. Investment Banking Agreement

BLOOMFIELD HILLS, MICHIGAN--(Marketwired - March 28, 2016) - Intrinsic4D Inc. ("Intrinsic4D") (TSX VENTURE:IFD) announced today that it has signed an engagement letter with New York based...
March 28, 2016 20:09 ET | Source: H. Lundbeck A/S

Lundbeck og Takeda modtager Complete Response Letter i USA vedrørende sNDA for Brintellix

Valby, Danmark og Osaka, Japan, 29. marts 2016 – H. Lundbeck A/S (Lundbeck) og Takeda Pharmaceutical Company Limited (Takeda) meddeler i dag, at selskaberne har modtaget et såkaldt Complete Response...
March 28, 2016 20:09 ET | Source: H. Lundbeck A/S

Lundbeck and Takeda receive Complete Response Letter by the FDA for Brintellix® (vortioxetine) sNDA

Valby, Denmark and Otsaka, Japan, 29 March 2016 - Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the U.S. Food and Drug Administration (FDA)...
March 28, 2016 17:00 ET | Source: Viatar CTC Solutions Inc.

Viatar CTC Solutions Announces Filing of 10-K Annual Report

LOWELL, MA--(Marketwired - Mar 28, 2016) - Viatar CTC Solutions, Inc. (OTCQB: VRTT), the cancer dialysis company, today filed its annual report on Form 10-K with the Securities and Exchange...
March 28, 2016 16:05 ET | Source: Larimar Therapeutics, Inc.

Zafgen to Present Data from bestPWS Study of Beloranib in Prader-Willi Syndrome at ENDO 2016

BOSTON, March 28, 2016 (GLOBE NEWSWIRE) -- Zafgen Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and...
March 28, 2016 16:01 ET | Source: Zevra Therapeutics

KemPharm Receives Clearance from FDA to Initiate Human Clinical Trials of KP511, an Investigational Prodrug of Hydromorphone

CORALVILLE, Iowa, March 28, 2016 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH) announced today that its Investigational New Drug (IND) application for KP511, KemPharm’s prodrug of...
March 28, 2016 14:05 ET | Source: B. Braun Medical Inc.

B. Braun Medical Inc. Issues Voluntary Nationwide Recall of Lot J5J706, 5% Dextrose Injection USP in PAB(R) Container Due to Leakage and/or Particulate Matter Identified to Be Microbial Growth

IRVINE, CA--(Marketwired - Mar 28, 2016) - B. Braun Medical Inc. is voluntarily recalling one lot of 5% Dextrose Injection USP 100/150mL container (Lot #J5J706, catalog # S5104-5264, NDC...
March 28, 2016 12:28 ET | Source: Levi & Korsinsky, LLP

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of PTC Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of May 2, 2016 – PTCT

NEW YORK, March 28, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of...
March 28, 2016 12:00 ET | Source: Sonendo

Sonendo® receives FDA 510(k) Clearance for the next generation of the GentleWave® System

LAGUNA HILLS, Calif., March 28, 2016 (GLOBE NEWSWIRE) -- Sonendo announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the next generation of it’s...
March 28, 2016 10:00 ET | Source: TissueGen Inc.

TissueGen Announces ISO13485:2003 Certification and Record Growth Driven by ELUTE Fiber

DALLAS, TX--(Marketwired - Mar 28, 2016) - TissueGen® Inc., developer of ELUTE® fiber, controlled, sustained drug delivery from bioresorbable fiber, has been awarded ISO13485:2003...
March 28, 2016 09:30 ET | Source: Merit Medical Systems, Inc.

Merit Medical Announces 510(k) Clearance for Corvocet™ Biopsy System

SOUTH JORDAN, Utah, March 28, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in...
March 28, 2016 08:30 ET | Source: Lipocine Inc.

Lipocine Announces the Presentation of Clinical Data for LPCN 1021, Its Oral Testosterone Replacement Therapy Product Candidate, at the American Society of Andrology 41st Annual Conference

SALT LAKE CITY, March 28, 2016 (GLOBE NEWSWIRE) -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced that clinical data for LPCN 1021, an oral testosterone...
March 28, 2016 08:30 ET | Source: MonoSol Rx

MonoSol Rx Successfully Completes Pre-IND Meeting with the FDA for PharmFilm® Tadalafil

WARREN, N.J., March 28, 2016 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm drug delivery technology to improve patient outcomes and address unmet needs,...
March 28, 2016 08:30 ET | Source: Lipocine Inc.

Lipocine Announces the Presentation of Clinical Data for LPCN 1021, Its Oral Testosterone Replacement Therapy Product Candidate, at ENDO 2016

SALT LAKE CITY, March 28, 2016 (GLOBE NEWSWIRE) -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced that clinical data for LPCN 1021, an oral testosterone...
March 28, 2016 08:30 ET | Source: Mateon Therapeutics

OXiGENE Reports 2015 Financial Results

SOUTH SAN FRANCISCO, Calif., March 28, 2016 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of cancer,...
March 28, 2016 08:30 ET | Source: Hagens Berman Sobol Shapiro LLP

Hagens Berman Reminds PTC Therapeutics (NASDAQ: PTCT) Investors of May 2, 2016 Lead Plaintiff Deadline in a Newly Filed Class Action

SAN FRANCISCO, March 28, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm reminds PTC Therapeutics (NASDAQ:PTCT) investors of the May 2, 2016 lead...
March 28, 2016 08:30 ET | Source: CervoMed Inc.

Diffusion Pharmaceuticals Provides Corporate Highlights and Reports 2015 Financial Results

CHARLOTTESVILLE, Va., March 28, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
March 28, 2016 08:01 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics, Inc. Reports Recent Business Highlights and Year-end 2015 Financial Results

NEWTOWN, Pa., March 28, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
March 28, 2016 08:00 ET | Source: Earth Science Tech, Inc.

Earth Science Tech Announces Strategic Alliance with RRNP Healthcare and Dysfunctional Veterans of New Hampshire to conduct its First 30-Day PTSD Clinical Study with Veterans using ETST High Grade Hemp CBD (Cannabidiol) Oil

Boca Raton, March 28, 2016 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (ETST) ("ETST" or "the Company"), a biotechnology company focused on nutraceuticals, bioceuticals and...
March 28, 2016 08:00 ET | Source: Neothetics, Inc.

Neothetics Provides Update and Plan Forward for LIPO-202 Program

SAN DIEGO, March 28, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today provided an update and plan forward for its LIPO-202 program. Neothetics plans to initiate a Phase 2 trial with...
March 28, 2016 08:00 ET | Source: Streamex Corp.

BioSig Technologies Announces Advanced Research Program with Mayo Clinic

Minneapolis, MN, March 28, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) today announced the establishment of an advanced research program with Dr. Samuel Asirvatham at Mayo...
March 28, 2016 08:00 ET | Source: CymaBay Therapeutics, Inc.

CymaBay Therapeutics Announces Acceptance of Arhalofenate Phase 2b Gout Study Manuscript in Arthritis and Rheumatology

NEWARK, Calif., March 28, 2016 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), today announced the online publication of its Phase 2b study of arhalofenate, a novel dual-acting...
March 28, 2016 07:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma to Present at Bio-Europe Spring 2016 Conference

TEL-AVIV, Israel, March 28, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on the development...
March 28, 2016 07:00 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Appoints Geoffrey Parker to the Board of Directors

SOUTH SAN FRANCISCO, Calif., March 28, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Geoffrey Parker has been appointed to the Sunesis Board of...
March 28, 2016 07:00 ET | Source: Axsome Therapeutics, Inc.

Axsome Therapeutics Initiates Phase 3 Study of AXS-02 for Knee Osteoarthritis Associated with Bone Marrow Lesions

First Patient Enrolled in the COAST-1 StudyNon-Opioid, Oral, Targeted, Potentially First-in-Class Mechanism for PainNovel Biomarker-Based Approach for the Treatment of Knee Osteoarthritis...
March 28, 2016 07:00 ET | Source: Alder BioPharmaceuticals, Inc.

Alder Reports Phase 2b Trial of ALD403 Meets Primary and Secondary Endpoints Demonstrating Migraine Prevention in Patients with Chronic Migraine

Alder Also Reports Positive Phase 1 Data Supporting Quarterly Single Injection Dosing Strategy for ALD403 Alder to Host Conference Call at 8:30 a.m. Eastern Time Today BOTHELL, Wash., March 28,...
March 28, 2016 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Reports Top-Line Phase 2b Data for Fispemifene in Symptomatic Secondary Hypogonadism

Fispemifene Failed to Achieve Statistical Significance in Key Clinical Benefit Endpoints Despite Increase in Testosterone Levels Company Will Focus on Internal Pipeline, Including Expanding Market...
March 28, 2016 06:30 ET | Source: CytoDyn Inc.

CytoDyn to Present PRO 140 Monotherapy Clinical Results at ASM Microbe 2016 Conference

VANCOUVER, Wash., March 28, 2016 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new therapies for combating human immunodeficiency virus...
March 27, 2016 19:00 ET | Source: MediciNova, Inc.

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 in China

LA JOLLA, Calif., March 27, 2016 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock...
March 27, 2016 08:00 ET | Source: Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CTI BioPharma Corp. of Class Action Lawsuit and Upcoming Deadline – CTIC

NEW YORK, March 27, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against CTI BioPharma Corp. (“CTI BioPharma” or the “Company”) (NASDAQ:CTIC) and...
March 25, 2016 13:26 ET | Source: Axe Compute Inc

Amended - Skyline Medical Announces Commencement of Registered Exchange Offer for Outstanding Series A Warrants

MINNEAPOLIS, March 25, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) (the “Company”) today announced the commencement as of March 25, 2016 of its registered exchange offer (the...
March 25, 2016 13:12 ET | Source: Onxeo SA

Onxeo Announces Closing of DNA Therapeutics Acquisition

Onxeo gains access to AsiDNA compound, a first-in-class signal interfering DNA PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)-- Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO), an...
March 25, 2016 13:09 ET | Source: Onxeo SA

Onxeo gennemfører opkøbet af DNA Therapeutics

Onxeo får adgang til AsiDNA-produktet – et innovativt signal-interfererende DNA PARIS & KØBENHAVN, Danmark--(BUSINESS WIRE)-- Fondsbørsmeddelelse: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO), et...
March 25, 2016 13:09 ET | Source: Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PTC Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – PTCT

NEW YORK, March 25, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PTC Therapeutics, Inc. (“PTC Therapeutics” or the “Company”) (NASDAQ:PTCT)...
March 25, 2016 08:00 ET | Source: ProPhase Labs

ProPhase Labs to Release Fourth Quarter/Year End Results on Tuesday, March 29th

DOYLESTOWN, PA--(Marketwired - March 25, 2016) - ProPhase Labs (NASDAQ: PRPH) announced today that financial results for the fourth quarter, ended December 31, 2015, will be released before the...
March 25, 2016 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Host 2015 Financial Results and Company Update Conference Call on Wednesday, March 30, 2016

SEATTLE, WA--(Marketwired - Mar 25, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that it will host a conference call on Wednesday, March 30, 2016 at 4:30 pm eastern time to review...
March 24, 2016 17:30 ET | Source: BriaCell Therapeutics Corp.

BriaCell Announces Senior Management Change

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 24, 2016) - BriaCell Therapeutics Corp. (OTCQB:BCTXF) (TSX VENTURE:BCT) (the "Company") announces that Dr. Joseph Wagner has resigned his...
March 24, 2016 17:30 ET | Source: Axe Compute Inc

Skyline Medical Announces Commencement of Registered Exchange Offer for Outstanding Series A Warrants

MINNEAPOLIS, March 24, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) (the “Company”) today announced the commencement of its registered exchange offer (the “Exchange Offer”) to issue...
March 24, 2016 16:30 ET | Source: Axsome Therapeutics, Inc.

Axsome Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results

NEW YORK, March 24, 2016 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous...
March 24, 2016 16:15 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Acquires Magellan Diagnostics, Inc.

CINCINNATI, March 24, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) announced today that it has completed the acquisition of Magellan Biosciences, Inc. and its...
March 24, 2016 16:05 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results

BERKELEY HEIGHTS, N.J., March 24, 2016 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP); "Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
March 24, 2016 16:01 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2015 Results

TUCSON, Ariz., March 24, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments and reagents for molecular profiling applications, today reported...
March 24, 2016 16:00 ET | Source: The Spectranetics Corporation

Spectranetics Names Udo Scheiner as Senior Vice President, International Operations

COLORADO SPRINGS, Colo., March 24, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Udo Scheiner has been named Senior Vice President, International...
March 24, 2016 14:21 ET | Source: Gordon Schanzlin New Vision Institute

Contoura Vision: San Diego LASIK Surgeons Discuss "Revolutionary" Topography-Guided Laser Vision Correction

SAN DIEGO, CA--(Marketwired - Mar 24, 2016) - Millions of Americans have undergone LASIK laser vision correction to reduce, or even eliminate, their need for eyeglasses and contact lenses. With the...
March 24, 2016 13:37 ET | Source: Weston A. Price Foundation

Feds Taint Raw Milk Investigation; Soil Farmer’s Reputation

Washington DC, March 24, 2016 (GLOBE NEWSWIRE) -- In a March 18, 2016 press release, the Centers for Disease Control (CDC) claimed a link between a “Multistate Outbreak of Listeriosis” and raw milk...
March 24, 2016 12:04 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Development and Commercialization Term Sheet with a Global Pharmaceutical Company for Up to Three Products

SAINT-LAURENT, CANADA--(Marketwired - March 24, 2016) - IntelGenx Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), today announced the signing of a term sheet with a global pharmaceutical company...
March 24, 2016 09:54 ET | Source: Research and Markets

Connected Drug Injection Devices to 2020

Dublin, March 24, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/jjc7rt/connected_drug) has announced the addition of the "Connected Drug...